Non-investigational Medicinal Products (NIMPs) are products which are not the object of theinvestigation, but supplied to a subject in a trial and used as per

Blinding of Parenteral formulation drugs involve unique challenges related to physical differenceof IMP and the components used to prepare active and placebo. Various blinding strategies

Strategic partnership and coordination is required to ensure that the study drug reaches clinicalsites well in time for the first subject first visit and the

Adaptive clinical trials can bring major benefits to the clinical trials through design modificationsbased on the results and interim data analysis. Features in adaptive clinical

The period of use (expiry date) is vital for a clinical trial and is strictly linked to the storageconditions. If the expiry date extension is